These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20530058)

  • 1. Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use.
    Zakharova MY; Meyer RM; Brandy KR; Datta YH; Joseph MS; Schreiner PJ; Rao GH; Divani AA
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):323-31. PubMed ID: 20530058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
    Tanis BC; Rosendaal FR
    Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk of oral contraceptives. Low, and mainly in women at risk.
    Prescrire Int; 1998 Aug; 7(36):118-24. PubMed ID: 10342951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal contraception, thrombosis and age.
    Lidegaard Ø
    Expert Opin Drug Saf; 2014 Oct; 13(10):1353-60. PubMed ID: 25227335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vascular disease and hormonal treatment--epidemiology].
    Vessey MP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives, hormone therapy and cardiovascular risk.
    Shapiro S
    Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and thrombosis. From risk estimates to health impact.
    Lidegaard O; Bygdeman M; Milsom I; Nesheim BI; Skjeldestad FE; Toivonen J
    Acta Obstet Gynecol Scand; 1999 Feb; 78(2):142-9. PubMed ID: 10023878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
    Gomes MP; Deitcher SR
    Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of hormonal contraceptives among women with migraine: A systematic review.
    Tepper NK; Whiteman MK; Zapata LB; Marchbanks PA; Curtis KM
    Contraception; 2016 Dec; 94(6):630-640. PubMed ID: 27153744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WHO scientific group meeting on cardiovascular disease and steroid hormone contraceptives.
    Wkly Epidemiol Rec; 1997 Nov; 72(48):361-3. PubMed ID: 9409187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined hormonal contraception and venous thromboembolism.
    Martínez F; Avecilla A
    Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular issues with oral contraceptives: evidenced-based medicine.
    Burkman RT
    Int J Fertil Womens Med; 2000; 45(2):166-74. PubMed ID: 10831186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits and risks of oral contraceptives.
    Drife J
    Adv Contracept; 1990 Dec; 6 Suppl():15-25. PubMed ID: 2291444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?
    Speroff L
    Johns Hopkins Med J; 1982 May; 150(5):170-6. PubMed ID: 7043035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of hormonal contraceptives for coronary heart disease].
    Gohlke-Bärwolf C
    Herz; 1987 Aug; 12(4):263-75. PubMed ID: 3308662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of cardiovascular events with hormonal contraception: insights from the Danish cohort study.
    Lalude OO
    Curr Cardiol Rep; 2013 Jul; 15(7):374. PubMed ID: 23715878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular events associated with different combined oral contraceptives: a review of current data.
    Hannaford P
    Drug Saf; 2000 May; 22(5):361-71. PubMed ID: 10830253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal contraceptives and arterial disease: an epidemiological update.
    Plu-Bureau G; Hugon-Rodin J; Maitrot-Mantelet L; Canonico M
    Best Pract Res Clin Endocrinol Metab; 2013 Feb; 27(1):35-45. PubMed ID: 23384744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic stroke and myocardial infarction with hormonal contraception.
    Lidegaard Ø; Løkkegaard E; Jensen A; Skovlund CW; Keiding N
    N Engl J Med; 2012 Jun; 366(24):2257-66. PubMed ID: 22693997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined contraceptives and cardiovascular risk].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.